Antiretroviral therapy allows a restoration of immune cell homeostasis associated with a normal immune competence. Our goal was to analyze the modulation of polyfunctional HIV-specific CD8+ T-cell responses during antiretroviral therapy. HIV-infected individuals were divided into four groups according to CD4+ cell count and viral load at the moment of recruitment. Whole blood was stimulated with a pool of CD8-specific HIV-antigens to assess cytokine/chemokine production and cytotoxicity activity by using flow cytometry. The groups show different modulation in HIV-specific CD8+ T-cell responses. In particular, immunological failure showed different distributions of polyfunctional HIV-specific CD8+ responses, mainly due to an increase of cells producing CD107a/IFN/γ/IL-2/MIP-1β. Our results indicate that this particular 4+ functional subset is a possible correlate of immunological failure. Considering the complexity of interactions among HAART, immune system and HIV, work is in progress to find correlates of therapy efficacy.
BorrowPLewickiHHahnBHShawGMOldstoneMB. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol1994; 68:6103–10.
2.
KoupRASafritJTCaoYAndrewsCAMcLeodGBorkowskyWFarthingCHoDD. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol1994; 68:4650–5.
3.
BordoniVCasettiRCapuanoGDeSBPiselliPGioiaCAgratiCMartiniF. A novel 8-color flow cytometry panel to study activation, maturation and senescence of CD4 and CD8 T lymphocytes in HIV-infected individuals at different stages of disease. Int J Immunopathol Pharmacol2012; 25:415–24.
4.
BordoniVAgratiCRinaldiAViolaDDeSGGioiaCMartiniF. In HIV-infected patients, some differential alterations of CD4 and CD8 T-cell homeostasis may not be restored by >/= 7 years of highly active antiretroviral therapy, in spite of good CD4 T-cell repopulation. J Antimicrob Chemother2012; 67:1802–4.
5.
FleurySRizzardiGPChapuisA. Long-term kinetics of T-cell production in HIV-infected subjects treated with highly active antiretroviral therapy. Proc Natl Acad Sci U S A2000; 97:5393–8.
6.
KovacsJALempickiRASidorovIA. Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIVJ Exp Med2001; 194:1731–41.
7.
MohriHPerelsonASTungK. Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy. J Exp Med2001; 194:1277–87.
8.
BettsMRAmbrozakDRDouekDCBonhoefferSBrenchleyJMCasazzaJPKoupRAPickerLJ. Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: Relationship to viral load in untreated HIV infection. J Virol2001; 75:11983–91.
9.
Gea-BanaclocheJCMiguelesSAMartinoL. Maintenance of large numbers of virus-specific CD8+ T-cells in HIV-infected progressors and long-term nonprogressors. J Immunol2000; 165:1082–92.
10.
De RosaSCLuFXYuJ. Vaccination in humans generates broad T-cell cytokine responses. J Immunol2004; 173:5372–80.
11.
RoedererMBrenchleyJMBettsMRDe RosaSC. Flow cytometric analysis of vaccine responses: How many colors are enough?Clin Immunol2004; 110:199–205.
NemesEBertoncelliLLugliE. Cytotoxic granule release dominates gag-specific CD4+ T-cell response in different phases of HIV infection. AIDS2010; 24:947–57.
14.
NemesELugliEBertoncelliL. CD4+ T-cell differentiation, regulatory T-cells and gag-specific T lymphocytes are unaffected by CD4-guided treatment interruption and therapy resumption. AIDS2011; 25:1443–53.
15.
RehrMCahenzliJHaasAPriceDAGostickEHuberMKarrerUOxeniusA. Emergence of polyfunctional CD8+ T-cells after prolonged suppression of human immunodeficiency virus replication by antiretroviral therapy. J Virol2008; 82:3391–404.
16.
RoedererMNozziJLNasonMC. SPICE: Exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A2011; 79:167–74.
17.
CasazzaJPBettsMRPickerLJKoupRA. Decay kinetics of human immunodeficiency virus-specific CD8+ T-cells in peripheral blood after initiation of highly active antiretroviral therapy. J Virol2001; 75:6508–16.
18.
OggGSJinXBonhoefferS. Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. J Virol1999; 73:797–800.
19.
StreeckHBrummeZLAnastarioM. Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T-cells. PLoS Med2008; 5:e100.
20.
MiguelesSAWeeksKANouE. Defective human immunodeficiency virus-specific CD8+ T-cell polyfunctionality, proliferation, and cytotoxicity are not restored by antiretroviral therapy. J Virol2009; 83:11876–89.
21.
CelleraiCHarariAStaussHKinloch-DeLS. Early and prolonged antiretroviral therapy is associated with an HIV-1-specific T-cell profile comparable to that of long-term non-progressors. PLoS One2011; 6:e18164.
22.
ImamiNWestropSJGragedaNHerasimtschukAA. Long-Term Non-Progression and Broad HIV-1-Specific Proliferative T-Cell Responses. Front Immunol2013; 4:58.
23.
AkinsikuOTBansalASabbajSHeathSLGoepfertPA. Interleukin-2 production by polyfunctional HIV-1-specific CD8 T-cells is associated with enhanced viral suppression. J Acquir Immune Defic Syndr2011; 58:132–40.
